devjit tripathy

Professor

University of Texas Health Science Center at San Antonio

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Devjit Tripathy is a Professor at The University of Texas Health Science Center at San Antonio, USA. His research focuses on diabetes and metabolism, with recent publications exploring the effects of various medications on glucose kinetics, insulin sensitivity, and lipid metabolism in both diabetic and healthy subjects. He has made significant contributions to understanding the cardioprotective effects of pioglitazone and the impact of hyperglycemia on metabolic processes.

Articles (10)

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

Assistant Professor

The University of Texas Rio Grande Valley - Edinburg Campus

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

devjit tripathy

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects

Effects of Sustained Hyperglycemia on Skeletal Muscle Lipids in Healthy Subjects.

Response to Letter to the Editor from Roy et al: “Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function”

Further evidence supporting a potential role for ADH1B in obesity.

Cardioprotective Effects of Pioglitazone in Type 2 Diabetes

Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance, and Insulin Sensitivity in Healthy Glucose-Tolerant Subjects

The Insulin-Sensitizer Pioglitazone Remodels Adipose Tissue Phospholipids in Humans.

Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function.

Pioglitazone corrects dysregulation of skeletal muscle mitochondrial proteins involved in ATP synthesis in type 2 diabetes.

Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.

Collaborators (5)

Srinivas Mummidi

Carolina Solis-Herrera

Satish Kumar

Swapan Das

Juan Lopez-Alvarenga

Make your next move.